Skip to main content
. 2009 Jan 19;29(6):620–625. doi: 10.1159/000194455

Table 1.

Cohort with and without CKD

CKD present (n = 17,463)
CKD absent (n = 17,519)
p value
MDRD eGFR 49.27±19.32 85.48±23.50 <0.001
eGFR
 <15 467 (2.7) <0.001
 15–29 1,162 (6.7)
 30–44 3,839 (21.9)
 45–59 11,995 (68.7)
 ≥60 0 (0.00) 17,519 (100.0)
Age, years 70.25±14.00 52.49±15.61 <0.001
Age group
 18–49 years 1,652 (9.5) 7,527 (42.9) <0.001
 50–59 years 2,054 (11.8) 4,290 (24.5)
 60–69 years 3,766 (21.6) 3,087 (17.6)
 70–79 years 5,208 (29.8) 1,774 (10.1)
 80+ years 4,783 (27.4) 841 (4.8)
Race
 Caucasian 15,422 (88.3) 14,133 (80.7) <0.001
 African-American 1,610 (9.2) 2,556 (14.6)
 Hispanic 292 (1.7) 538 (3.1)
 Asian 127 (0.7) 278 (1.6)
 Native American 12 (0.07) 14 (0.08)
Gender
 Female 10,844 (62.1) 9,577 (54.7) <0.001
 Male 6,619 (37.9) 7,942 (45.3)
Hypertension 13,238 (75.8) 6,777 (38.7) <0.001
Anemia 7,268 (41.6) 2,441 (13.9) <0.001
Diabetes 6,325 (36.2) 3,087 (17.6) <0.001
CVD 12,467 (71.4) 6,443 (36.8) <0.001

Values are expressed as mean ± standard deviation for age and MDRD-estimated GFR. Otherwise, values expressed as n (%). Differences between groups for categorical and continuous variables were examined using χ2 tests Student's t tests, respectively. MDRD-estimated GFRs are measured in ml/min/1.73 m2. Comorbid conditions (hypertension, anemia, diabetes, and CVD) are based on ICD-9 diagnosis codes identified through Strong Health medical records.